Total Valuation
Quantum Biopharma has a market cap or net worth of €25.71M. The enterprise value is €19.07.
Market Cap€25.71M
Enterprise Value€19.07
Share Statistics
Quantum Biopharma has 8,087,479 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,087,479
Owned by Insiders10.68%
Owned by Institutions3.03%
Financial Efficiency
Quantum Biopharma’s return on equity (ROE) is -3.79 and return on invested capital (ROIC) is -219.67%.
Return on Equity (ROE)-3.79
Return on Assets (ROA)-2.35
Return on Invested Capital (ROIC)-219.67%
Return on Capital Employed (ROCE)-3.00
Revenue Per Employee0.00
Profits Per Employee-2.91M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Quantum Biopharma is ―. Quantum Biopharma’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value3.47
Price to FCF0.00
Price to Operating Cash Flow-4.57
PEG Ratio―
Income Statement
In the last 12 months, Quantum Biopharma had revenue of 0.00 and earned -26.18M in profits. Earnings per share was -8.11.
Revenue0.00
Gross Profit0.00
Operating Income-15.30M
Pretax Income-26.96M
Net Income-26.18M
EBITDA-25.79M
Earnings Per Share (EPS)-8.11
Cash Flow
In the last 12 months, operating cash flow was -5.42M and capital expenditures -6.00, giving a free cash flow of -5.42M billion.
Operating Cash Flow-5.42M
Free Cash Flow-5.42M
Free Cash Flow per Share-0.67
Dividends & Yields
Quantum Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change-81.33%
50-Day Moving Average2.71
200-Day Moving Average3.88
Relative Strength Index (RSI)55.71
Average Volume (3m)626.00
Important Dates
Quantum Biopharma upcoming earnings date is Nov 6, 2026, Before Open (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateNov 6, 2026
Ex-Dividend Date―
Financial Position
Quantum Biopharma as a current ratio of 1.07, with Debt / Equity ratio of 12.12%
Current Ratio1.07
Quick Ratio1.06
Debt to Market Cap0.08
Net Debt to EBITDA<0.01
Interest Coverage Ratio-24.74
Taxes
In the past 12 months, Quantum Biopharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Quantum Biopharma EV to EBITDA ratio is -0.93, with an EV/FCF ratio of -2.86.
EV to Sales0.00
EV to EBITDA-0.93
EV to Free Cash Flow-2.86
EV to Operating Cash Flow-2.86
Balance Sheet
Quantum Biopharma has €9.73M in cash and marketable securities with ― in debt, giving a net cash position of €8.77M billion.
Cash & Marketable Securities€9.73M
Total Debt―
Net Cash€8.77M
Net Cash Per Share€1.08
Tangible Book Value Per Share€0.18
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Quantum Biopharma is €6.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€6.90
Price Target Upside176.18% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast59.35%